Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024One More Inpharmatis Team Member Gets PhD in Pharmaceutical Sciences
Konstantin Koshechkin, Head of Electronic Solutions at Inpharmatis, has successfully become PhD in Pharmaceutical Sciences.
The research paper was devoted to "Methodology for the digital transformation of the registration of medicines as a stage of the life cycle." The defense took place at the Sechenov First Moscow State Medical University.
“The key challenge is the continuing extreme heterogeneity of data describing medicines in the data systems. The presentation of data in digital format during scientific expertise allows to transform and intensify all subsequent stages of life cycle. The introduction of electronic registration dossiers also provides for faster examination of medicines, which ensures that patients can access new medicines without delay,” as stated in the introduction of Konstantin Koshechkin’s doctoral dissertation.
Within the Inpharmatis Group, PhD in Pharmaceutical Sciences Konstantin Koshechkin heads the department of electronic solutions for the pharmaceutical industry and regulators. Under his direct supervision, many projects have been implemented, including introducing of electronic dossier (eCTD), digitalization of the quality management system in pharmaceutical production, and developing of the Inpharmatis' own software products.
Challenges of Medical Devices Registration in the EAEU
March 26, 2024Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks
February 28, 2024Получение GMP сертификата ЕАЭС обязательная процедура
February 21, 2024EAEU GMP Certificate is Mandatory
February 20, 2024Полина Домбуре, директор Inpharmatis, приняла участие в TOPRA Summit 2024
February 19, 2024Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
February 19, 2024